| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2024 | Nov 12, 2024 | Savara Inc | Chief Medical Officer | Sell | 22.5 | -49,950 | -16.11% | ✗ | $198.3K |
| Jun 26, 2023 | Jun 27, 2023 | Savara Inc | Chief Medical Officer | Buy | 83.8 | +6,500 | 4.23% | ✗ | $19K |
| Dec 22, 2022 | Dec 22, 2022 | Savara Inc | Chief Medical Officer | Buy | 77.5 | +3,500 | 2.33% | ✗ | $5.4K |
| Apr 26, 2020 | Apr 27, 2020 | ROCKWELL MEDICAL, INC. | VP of Drug Development | Sell | 46.3 | -4,612 | -1.29% | ✗ | $10.5K |
| Jun 21, 2017 | Jun 23, 2017 | ROCKWELL MEDICAL, INC. | VP of Drug Development | Sell | 40.0 | -76,230 | -19.34% | ✗ | $548.9K |
| Aug 13, 2015 | Aug 14, 2015 | ROCKWELL MEDICAL, INC. | VP of Drug Development | Buy | 87.5 | +5,000 | 3.21% | ✗ | $57.7K |
| May 1, 2015 | May 5, 2015 | ROCKWELL MEDICAL, INC. | VP of Drug Development | Sell | 40.0 | -34,650 | -18.20% | ✗ | $334K |
| Mar 2, 2015 | Mar 3, 2015 | ROCKWELL MEDICAL, INC. | VP of Drug Development | Sell | 40.0 | -34,650 | -15.40% | ✗ | $362.8K |